Abel Makubi

486 total citations
24 papers, 218 citations indexed

About

Abel Makubi is a scholar working on Genetics, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Abel Makubi has authored 24 papers receiving a total of 218 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 14 papers in Hematology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Abel Makubi's work include Iron Metabolism and Disorders (14 papers), Hemoglobinopathies and Related Disorders (14 papers) and Prenatal Screening and Diagnostics (4 papers). Abel Makubi is often cited by papers focused on Iron Metabolism and Disorders (14 papers), Hemoglobinopathies and Related Disorders (14 papers) and Prenatal Screening and Diagnostics (4 papers). Abel Makubi collaborates with scholars based in Tanzania, United States and United Kingdom. Abel Makubi's co-authors include Julie Makani, Bruno P. Mmbando, Sayoki Mfinanga, Esther Ngadaya, Nyanda Elias Ntinginya, Sharon E. Cox, Furahini Tluway, Emmanuela E. Ambrose, Swee Lay Thein and Russell E. Ware and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Abel Makubi

21 papers receiving 211 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abel Makubi Tanzania 9 105 97 34 32 29 24 218
Ahmar U. Zaidi United States 10 203 1.9× 165 1.7× 69 2.0× 40 1.3× 15 0.5× 33 309
Çiğdem Gereklioğlu Türkiye 8 118 1.1× 111 1.1× 72 2.1× 42 1.3× 3 0.1× 48 285
René M. Ngiyulu Democratic Republic of the Congo 12 138 1.3× 119 1.2× 67 2.0× 37 1.2× 13 0.4× 18 304
Reena K. Gulati United States 7 79 0.8× 57 0.6× 32 0.9× 43 1.3× 2 0.1× 14 164
Behin Yektashenas United States 4 69 0.7× 103 1.1× 15 0.4× 56 1.8× 9 260
Henrik Hjalgrim Denmark 11 36 0.3× 56 0.6× 57 1.7× 14 0.4× 4 0.1× 17 266
Christine A. Johnson United States 9 71 0.7× 105 1.1× 47 1.4× 12 0.4× 12 0.4× 14 293
John S James United States 6 56 0.5× 44 0.5× 21 0.6× 18 0.6× 6 0.2× 49 168
Regina B. Butler United States 13 65 0.6× 310 3.2× 9 0.3× 59 1.8× 12 0.4× 32 462
Eugenia Vicky Asare Ghana 6 98 0.9× 79 0.8× 61 1.8× 11 0.3× 3 0.1× 12 166

Countries citing papers authored by Abel Makubi

Since Specialization
Citations

This map shows the geographic impact of Abel Makubi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abel Makubi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abel Makubi more than expected).

Fields of papers citing papers by Abel Makubi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abel Makubi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abel Makubi. The network helps show where Abel Makubi may publish in the future.

Co-authorship network of co-authors of Abel Makubi

This figure shows the co-authorship network connecting the top 25 collaborators of Abel Makubi. A scholar is included among the top collaborators of Abel Makubi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abel Makubi. Abel Makubi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Makubi, Abel, Andreas Müeller, John Changalucha, et al.. (2024). Virological impact of HIV drug-resistance testing in children, adolescents, and adults failing first-line ART in Tanzania. Journal of Global Antimicrobial Resistance. 39. 73–81. 1 indexed citations
3.
Makani, Julie, Furahini Tluway, Raphael Zozimus Sangeda, et al.. (2024). The epidemiology of very severe anaemia in sickle cell disease in Tanzania: a prospective cohort study. EClinicalMedicine. 76. 102839–102839.
4.
Kamala, Benjamin, Maarten J. Cramer, Pilly Chillo, et al.. (2024). Predictors of early mortality following cardiac surgery for rheumatic heart disease at a national referral hospital in Dar es Salaam, Tanzania: A retrospective study. East and Central African journal of surgery. 27(2). 42–50.
5.
Paintsil, Vivian, Mwashungi Ally, Kofi A. Anie, et al.. (2023). Development of multi-level standards of care recommendations for sickle cell disease: Experience from SickleInAfrica. Frontiers in Genetics. 13. 8 indexed citations
6.
Ambrose, Emmanuela E., Teresa Latham, Adam Lane, et al.. (2023). Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trial. The Lancet Haematology. 10(4). e261–e271. 18 indexed citations
7.
Smart, Luke R., Emmanuela E. Ambrose, Thad A. Howard, et al.. (2022). Stroke Prevention with Hydroxyurea Enabled through Research and Education: A Phase 2 Primary Stroke Prevention Trial in Sub-Saharan Africa. Acta Haematologica. 146(2). 95–105. 6 indexed citations
8.
Mghamba, Janneth, Ndekya M. Oriyo, Elizabeth H. Shayo, et al.. (2022). Compliance to infection prevention and control interventions for slowing down COVID-19 in early phase of disease transmission in Dar es Salaam, Tanzania. Pan African Medical Journal. 41. 174–174. 7 indexed citations
9.
10.
Mfinanga, Sayoki, et al.. (2021). Tanzania's position on the COVID-19 pandemic. The Lancet. 397(10284). 1542–1543. 41 indexed citations
11.
Kija, Edward, Siana Nkya, Bruno P. Mmbando, et al.. (2020). Clinical epidemiology of individuals with Sickle cell anemia using Hydroxyurea at Muhimbili National Hospital, Dar Es Salaam, Tanzania. 31(1). 106–119. 3 indexed citations
12.
Ambrose, Emmanuela E., Luke R. Smart, Thad A. Howard, et al.. (2020). Hydroxyurea to Reduce Stroke Risk in Tanzanian Children with Sickle Cell Anemia. Blood. 136(Supplement 1). 20–21. 2 indexed citations
13.
Kingery, Justin R., Parag Goyal, Myung Hee Lee, et al.. (2020). Human Immunodeficiency Virus–Associated Myocardial Diastolic Dysfunction and Soluble ST2 Concentration in Tanzanian Adults: A Cross-Sectional Study. The Journal of Infectious Diseases. 223(1). 83–93. 9 indexed citations
14.
15.
Lee, Nathaniel, Julie Makani, Furahini Tluway, et al.. (2018). Decreased Hepcidin Levels Are Associated with Low Steady-state Hemoglobin in Children With Sickle Cell Disease in Tanzania. EBioMedicine. 34. 158–164. 10 indexed citations
16.
Makani, Julie, Furahini Tluway, Abel Makubi, et al.. (2018). A ten year review of the sickle cell program in Muhimbili National Hospital, Tanzania. SHILAP Revista de lepidopterología. 18(1). 33–33. 34 indexed citations
17.
Nkya, Siana, Josephine Mgaya, Abel Makubi, et al.. (2017). Fetal Hemoglobin is Associated with Peripheral Oxygen Saturation in Sickle Cell Disease in Tanzania. EBioMedicine. 23. 146–149. 10 indexed citations
18.
Makubi, Abel, Philip Sasi, Enrico M. Novelli, et al.. (2016). Rationale and design of mDOT-HuA study: a randomized trial to assess the effect of mobile-directly observed therapy on adherence to hydroxyurea in adults with sickle cell anemia in Tanzania. BMC Medical Research Methodology. 16(1). 140–140. 10 indexed citations
19.
Makubi, Abel, Camilla Hage, Johnson Lwakatare, et al.. (2014). Prevalence and prognostic implications of anaemia and iron deficiency in Tanzanian patients with heart failure. Heart. 101(8). 592–599. 20 indexed citations
20.
Makubi, Abel, Deogratius Soka, & Julie Makani. (2012). Moyamoya Disease, a Rare Cause of Recurrent Strokes in an African Sickle Cell Child: Does hydroxyurea have a Role in this Context?. International Journal of Child Health and Nutrition. 1(1). 82–85. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ahmar U. Zaidi Breakdown of academic impact, for papers by Çiğdem Gereklioğlu Breakdown of academic impact, for papers by René M. Ngiyulu Breakdown of academic impact, for papers by Reena K. Gulati Breakdown of academic impact, for papers by Behin Yektashenas Breakdown of academic impact, for papers by Henrik Hjalgrim Breakdown of academic impact, for papers by Christine A. Johnson Breakdown of academic impact, for papers by John S James Breakdown of academic impact, for papers by Regina B. Butler Breakdown of academic impact, for papers by Eugenia Vicky Asare
Rankless by CCL
2026